Artia Global Partners’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.88M	Sell	180,731 -538,634	-75%	-$17.3M	1.33%	16
2025 Q4	$25.3M	Buy	719,365 +573,186	+392%	+$20.3M	4.07%	6
2025 Q3	$3.84M	Buy	146,179 +49,700	+52%	+$1.48M	0.68%	25
2025 Q2	$2.56M	Buy	96,479 +6,200	+7%	+$163K	0.66%	22
2025 Q1	$2.18M	Hold	90,279	–	–	0.64%	22
2024 Q4	$3.63M	Sell	90,279 -442,600	-83%	-$25.2M	1.47%	20
2024 Q3	$33.7M	Buy	532,879 +79,900	+18%	+$4.69M	9.54%	3
2024 Q2	$24M	Buy	452,979 +19,399	+4%	+$1.27M	6.16%	6
2024 Q1	$35.6M	Buy	433,580 +50,000	+13%	+$2.22M	8.72%	5
2023 Q4	$7.14M	Hold	383,580	–	–	2.82%	10
2023 Q3	$4.25M	Hold	383,580	–	–	1.77%	15
2023 Q2	$6.22M	Buy	383,580 +315,172	+461%	+$6.6M	2.14%	19
2023 Q1	$1.14M	Sell	68,408 -62,505	-48%	-$646K	0.46%	27
2022 Q4	$1.23M	Buy	+130,913	New	+$584K	0.47%	21